The importance of quantifying the adverse effects on healthcare-related quality of life in people with benign gynecologic conditions

This paper argues for the critical importance of quantifying adverse effects on healthcare-related quality of life within the context of benign gynecologic conditions. The authors highlight that while treatment efficacy is often measured by clinical outcomes, patient-reported experiences regarding quality of life are equally vital for comprehensive care assessment. By emphasizing this metric, the study advocates for a more holistic approach to evaluating therapeutic interventions in gynecology. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works